Welcome to our dedicated page for OPY Acquisition I news (Ticker: OHAAU), a resource for investors and traders seeking the latest updates and insights on OPY Acquisition I stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect OPY Acquisition I's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of OPY Acquisition I's position in the market.
OPY Acquisition Corp. I (NASDAQ: OHAAU) reported that underwriters fully exercised their over-allotment option during the IPO, acquiring an additional 1,650,000 units on November 5, 2021. This action resulted in gross proceeds of $16,500,000, with total gross proceeds from the offering reaching $126,500,000. Each unit comprises one share of Class A common stock and one-half of a redeemable warrant, with the units priced at $10.00 each. The stock and warrants will soon trade separately under the symbols "OHAA" and "OHAAW," respectively.
OPY Acquisition Corp. I has successfully closed its upsized IPO, issuing 11 million units at $10.00 each. Each unit includes one share of Class A common stock and one-half of a redeemable warrant, with whole warrants priced at $11.50. An additional option for underwriters allows the purchase of 1.65 million units. Trading on Nasdaq began on October 27, 2021, under the symbol OHAAU. The company aims to target the life sciences sector for future business combinations.
OPY Acquisition Corp. I has announced the pricing of its initial public offering (IPO) of 11,000,000 units at $10.00 each, consisting of one share of Class A common stock and one-half of a redeemable warrant. Each whole warrant allows the purchase of one additional share at $11.50. The offering is set to trade on Nasdaq under the symbol 'OHAAU' starting October 27, 2021, with expected closing on October 29, 2021. Oppenheimer & Co. Inc. and Lake Street Capital Markets are acting as joint book-running managers.
OPY Acquisition Corp. I has launched its initial public offering (IPO) roadshow, planning to sell 10 million units at $10.00 each. Each unit includes one share of Class A common stock and one-half of a redeemable warrant. The warrants allow purchasing additional shares at $11.50. The units will trade on Nasdaq under the ticker symbol OHAAU. Oppenheimer & Co. Inc. and Lake Street Capital Markets are the offering's joint book-running managers. The IPO is subject to SEC approval and market conditions.
